Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12888908rdf:typepubmed:Citationlld:pubmed
pubmed-article:12888908lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:12888908lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12888908lifeskim:mentionsumls-concept:C0699791lld:lifeskim
pubmed-article:12888908lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:12888908lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:12888908lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:12888908pubmed:issue3lld:pubmed
pubmed-article:12888908pubmed:dateCreated2003-7-30lld:pubmed
pubmed-article:12888908pubmed:abstractTextThe Fas-Fas ligand system is one of the factors involved in cell death signaling. Aberrations in the signaling pathways leading to Fas-mediated apoptosis in tumor cells have been reported in a variety of human malignant tumors. However, the Fas-mediated apoptotic pathway has not been sufficiently elucidated in human gastric carcinomas. We examined the apoptotic pathway induced by anti-Fas antibody using seven human gastric carcinoma cell lines. Apoptosis was induced in a delayed fashion and the apoptotic indices (AI) after 48 h were approximately 30-40% in MKN-45 and KATO-III cells, which both showed cleavage of the Bid protein and release of Cytochrome c from the mitochondria. Our data also demonstrated no significant relationship between the expressions of various apoptosis-related proteins and the sensitivity or resistance to anti-Fas antibody-induced apoptosis, as far as we examined. Furthermore, the apoptosis signal was inhibited by treatment with Caspase-9 and -3 inhibitors in MKN-45 and KATO-III. These findings suggest that anti-Fas antibody induced apoptosis through the type II signaling pathway in the human gastric carcinoma cell lines, MKN-45 and KATO-III.lld:pubmed
pubmed-article:12888908pubmed:languageenglld:pubmed
pubmed-article:12888908pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:citationSubsetIMlld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12888908pubmed:statusMEDLINElld:pubmed
pubmed-article:12888908pubmed:monthSeplld:pubmed
pubmed-article:12888908pubmed:issn1019-6439lld:pubmed
pubmed-article:12888908pubmed:authorpubmed-author:ItoHisaoHlld:pubmed
pubmed-article:12888908pubmed:authorpubmed-author:KaseSatoruSlld:pubmed
pubmed-article:12888908pubmed:authorpubmed-author:OsakiMitsuhik...lld:pubmed
pubmed-article:12888908pubmed:authorpubmed-author:AdachiKeikoKlld:pubmed
pubmed-article:12888908pubmed:authorpubmed-author:TakedaAmiAlld:pubmed
pubmed-article:12888908pubmed:issnTypePrintlld:pubmed
pubmed-article:12888908pubmed:volume23lld:pubmed
pubmed-article:12888908pubmed:ownerNLMlld:pubmed
pubmed-article:12888908pubmed:authorsCompleteYlld:pubmed
pubmed-article:12888908pubmed:pagination713-9lld:pubmed
pubmed-article:12888908pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:meshHeadingpubmed-meshheading:12888908...lld:pubmed
pubmed-article:12888908pubmed:year2003lld:pubmed
pubmed-article:12888908pubmed:articleTitleAnti-Fas antibody-induced apoptosis and its signal transduction in human gastric carcinoma cell lines.lld:pubmed
pubmed-article:12888908pubmed:affiliationDivision of Organ Pathology, Department of Microbiology and Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori 683-8503, Japan.lld:pubmed
pubmed-article:12888908pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12888908pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed